COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,725 Articles (22,913 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 83: Articles 821-830  | Next

Seroprevalence, Knowledge, Attitudes, and Practices of People to COVID-19 in Chililabombwe and Lusaka Districts of Zambia.
Sampa, M., Siwila, J., Hangombe, B., Misinzo, G., Rweyemamu, M., Chipanta, C., Simuunza, M. C.
10.1101/2025.09.08.25335374 — Posted: 2025-09-12
A robust framework for harmonising health measures across international cohorts: Evidence from the COVID-19 pandemic.
Lian, J., Zuccolo, P. F., Ebrahimi, O. V., Fatori, D., Adlakha, A., De La Hoz, J. F., Lee, Y. H., Carneiro, A., Bensenor, I. M., Lotufo, P. A., Goulart, A. C., Tubbs, J. D., Watts, D., Zhou, Y., Dall'Aglio, L., Cudic, M., Kuenzi, M., COVID Global Mental Health Consortium, , Kessler, R. C., Patel, V., Brunoni, A., Smoller, J. W., Bauermeister, S.
10.1101/2025.09.09.25335409 — Posted: 2025-09-12
Towards a reliable diagnosis of long Covid.
Franke, A. D.
10.1101/2025.09.10.25335169 — Posted: 2025-09-12
A Multi-Country Qualitative Evaluation of Rapid Mortality Surveillance During the COVID -19 Pandemic
Congdon, C., Malik, F., Jina, R., Kumar, D., Setel, P.
10.1101/2025.09.11.25335597 — Posted: 2025-09-12
A Tale of Two Models: Linear Regression and Poisson GLM Yield Identical Trends for COVID-19 Mortality in Italy
Roccetti, M., Cacciapuoti, G.
10.1101/2025.09.11.25335570 — Posted: 2025-09-12
Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1
Maurmann, R. M., Davis, K., Mosalmanzadeh, N., Schmitt, B. L., Pence, B. D.
10.1101/2025.09.12.675877 — Posted: 2025-09-12
Mechanism of SARS-CoV-2 Nucleocapsid Protein Phosphorylation-induced Functional Switch
Sullivan, M. S., Morse, M., Grabarkewitz, K., Bayachou, D., Rouzina, I., Wysocki, V., Williams, M. C., Musier-Forsyth, K.
10.1101/2025.09.12.675721 — Posted: 2025-09-12
Clinical Surveillance Identifies SARS-CoV-2 Outbreaks and Emergence of Novel Variants in Real-Time
Holland, S. C., Shoemaker, I., Rosov, T., Compton, C., LaBaer, J., Lim, E. S., Murugan, V.
10.1101/2025.09.09.25335437 — Posted: 2025-09-11
Effectiveness of 2024/25 KP.2 vaccine against outpatient COVID-19 in Canada
Separovic, L., Sabaiduc, S., Zhan, Y., Kaweski, S. E., Carazo, S., Olsha, R., Mather, R. G., Lacroix, C., Hasso, M., Levade, I., Meunier, I., Jassem, A. N., Dover, K., Gao, R., Bastien, N., Skowronski, D. M.
10.1101/2025.09.05.25335203 — Posted: 2025-09-11
Chemical modulation of the unfolded protein response reveals an antiviral role for the PERK pathway in human coronavirus 229E infection
Pellizzari-Delano, I. E., Tooley, T. H., Jani, K., Gallardo-Flores, C. E., Colpitts, C. C.
10.1101/2025.09.11.675615 — Posted: 2025-09-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).